resources

Anthem Biosciences Ltd.

NSE: ANTHEM

BSE: 544449

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Biotechnology

957.80+24.3 (+2.60%)

8 Sep, 3:30 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Anthem Biosciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2025	2026
Annual Reports	—	FY 2026
Quarterly Results	Jun Sept Dec	Mar Jun
Conference Calls	18Aug 12Nov	9Feb 22May 27Jul
Presentations	13Aug 8Nov	5Feb 19May 21Jul

Corporate Announcements and Regulatory Filings

Anthem Biosciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

AGM24 Jul 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Anthem Biosciences Limited has submitted the Exchange the voting results and a copy of scrutinizer report of the 20th Annual General Meeting of the Company held on July 22, 2026
Analyst / Investor Meet22 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings Call for the quarter ended June 30, 2026.
Newspaper Publication22 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication on Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026
Press Release / Media Release (Revised)21 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Revised Press Release on Unaudited Financial Results for the quarter ended June 30, 2026
Press Release / Media Release21 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Consolidated Financial Results for the quarter ended June 30, 2026
Outcome of Board Meeting21 Jul 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, July 21, 2026
Outcome of the Board Meeting held on Tuesday, July 21, 2026
Analyst / Investor Meet15 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Earnings Conference Call to discuss on Unaudited Standalone and Consolidated Financial Results for quarter ended June 30, 2026
Board Meeting14 Jul 2026
Board Meeting Intimation for Financial Results For Quarter Ended June 30, 2026
Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2026 ,inter alia, to consider and approve Unaudited Standalone and ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation under 74(5) of SEBI (DP) Regulations, 2018
General8 Jul 2026
Letter To Shareholders
Letter to Shareholders providing the weblink and navigation path for accessing the Annual Report for the FY 2025-26 pursuant to Regulation 36(1)(b) of LODR.
Credit Rating3 Jul 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Revision in Credit Rating
General1 Jul 2026
Announcement Under Regulation 30 (LODR)- Newspaper Publication
Newspaper advertisement regarding the completion of dispatch of notice of the 20th Annual General Meeting of the Company
Reg. 34 (1) Annual Report30 Jun 2026
Reg. 34 (1) Annual Report.
Revised Annual Report for the FY 2025-26
Business Responsibility and Sustainability Reporting (BRSR)30 Jun 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report (BRSR) for the FY 2025-2026
Reg. 34 (1) Annual Report30 Jun 2026
Reg. 34 (1) Annual Report.
Annual Report for the FY 2025-26
AGM30 Jun 2026
Notice Of The 20Th Annual General Meeting ('AGM')
Notice of the 20th Annual General Meeting
Newspaper Publication29 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding pre-dispatch intimation of Notice of 20th Annual General Meeting of the Company
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Closure of Trading Window for the quarter ended June 30, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aruna Ganesh
Analyst / Investor Meet5 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Institutional Call to be held on June 10, 2026

Frequently Asked Questions

Where can I download the annual report of Anthem Biosciences Ltd.?

Annual reports of Anthem Biosciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Anthem Biosciences Ltd.?

Quarterly earnings results and presentations of Anthem Biosciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Anthem Biosciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Anthem Biosciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Anthem Biosciences Ltd.?

Investor presentations and annual day presentations of Anthem Biosciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Anthem Biosciences Ltd.?

Corporate announcements and regulatory filings of Anthem Biosciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Anthem Biosciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Anthem Biosciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Anthem Biosciences Ltd.?

The ISIN (International Securities Identification Number) of Anthem Biosciences Ltd. is INE0CZ201020. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Anthem Biosciences Ltd. listed?

Anthem Biosciences Ltd. is listed on NSE and BSE. The NSE symbol is ANTHEM and the BSE code is -.

Where can I find the shareholding pattern of Anthem Biosciences Ltd.?

The quarterly shareholding pattern of Anthem Biosciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Anthem Biosciences Ltd. on Sharpely?

Share price data for Anthem Biosciences Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.